IRWD FY 2008 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$591M

FY 2008 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$22M+112.3% YoY

Gross Profit

$22M100.0% margin

Operating Income

-$56M-251.7% margin

Net Income

-$54M-242.5% margin

EPS (Diluted)

$-0.77

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$51M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$141M

Total Liabilities

$371M

Stockholders' Equity

-$236M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$10M	+112.3%
Gross Profit	$22M	$10M	+112.3%
Operating Income	-$56M	-$58M	+2.9%
Net Income	-$54M	-$53M	-2.1%